Duluth, Ga. -- August 6, 2020 -- National Vision Holdings, Inc. (NASDAQ: EYE) (“National Vision” or the “Company”) today reported its financial results for the second quarter ended June 27, 2020.
“The second quarter represented one of the most eventful periods in our Company's history and our respective careers,” stated Reade Fahs, chief executive officer. “Following our March closings, we are pleased to have safely reopened our stores by early June. With our many new protocols in place, we believe we have an effective, safety first approach to serve patients and customers in a COVID-19 environment. While we expect the macro environment will continue to evolve, we believe we are well positioned to continue operations throughout the remainder of the COVID-19 pandemic.”
Mr. Fahs further commented, “Since reopening, our stores have experienced consistently strong demand from our patients and customers. June comps increased over 19%, the best reported comp increase in my 18 years at National Vision, with similar momentum continuing throughout July. Results were likely helped by pent-up demand during the lock-down and benefits from government stimulus payments. But performance also reflects successful macro and micro navigation of this dynamic situation by our operations and product teams. As our stores provide essential healthcare services and products, and given the state of the economy, we believe ever more consumers are drawn to our affordably priced eye exams, eyeglasses, and contact lenses.”
Mr. Fahs continued, “In May, we took the financial steps to strengthen our balance sheet and are confident in our financial flexibility and liquidity to navigate the remainder of the pandemic. In July, we were pleased to extend our 30-year partnership with Walmart for another three years into 2024. This contract extension comes on the heels of the successful transition of the five additional Vision Centers that Walmart granted in January. We have been encouraged by the initial results at these stores to date and see tremendous future potential for them as well.”
Mr. Fahs concluded, “As matters of diversity and inclusion are ever more on the minds of both consumers and associates, especially relative to the Black community, they remain a priority at National Vision as we strive to be an ever more inclusive workplace. In the second quarter, we established a Diversity, Equity and Inclusion Council to give a stronger voice to our Black associates and other minorities within the National Vision family. And, as we continue to strive to provide a life-giving culture for our associates and doctors who practice alongside our stores, we made investments in our people including a one-time $250 ‘appreciation’ bonus to our front line associates and network of doctors for their exceptional work under difficult circumstances over the past several months. I derive constant inspiration by the work and determination of the extended National Vision team. While there remains uncertainty about the future, I am confident that we will emerge stronger and better from this extraordinary experience.”
Adjusted Comparable Store Sales Growth, Adjusted EBITDA, Adjusted Operating Income, Adjusted Diluted EPS, Adjusted Operating Margin, Adjusted EBITDA Margin, and EBITDA are not measures recognized under generally accepted accounting principles (“GAAP”). Please see “Non-GAAP Financial Measures” and “Reconciliation of Non-GAAP to GAAP Financial Measures” below for more information.
COVID-19 Response Update
The Company continues to take actions to manage its business through the dynamic and challenging environment resulting from the COVID-19 pandemic. Following temporary store closures to the public in March 2020, the Company completed the process of reopening stores with enhanced safety and cleaning protocols in early June 2020. In addition, the Company continues to take actions to manage the business that the Company believes are prudent in these circumstances, including:
Given the uncertainties, dynamic nature, resurgence, and unknown duration of the pandemic, the Company is continuing to evaluate additional operational and financial measures that may be taken as the Company continues to respond to the impact of COVID-19 on its business.
Second Quarter 2020 Summary
Six-Month Period Highlights
Balance Sheet and Cash Flow Highlights as of June 27, 2020
Recent Developments
Fiscal 2020 Outlook
As previously disclosed, given the uncertainty surrounding the magnitude and duration of the COVID-19 pandemic, the Company withdrew its fiscal 2020 outlook on March 27, 2020 and is not providing an earnings outlook at this time. However, the Company is providing the following updated assumptions for fiscal 2020:
New Stores
50 - 55 New Stores
Depreciation and Amortization1
$94 - $95 million
Interest2
$33 - $34 million
Capital Expenditures
$65 - $75 million
Incremental COVID-19 Expenses
~$8 million
1 - Includes amortization of acquisition intangibles of approximately $7.4 million 2 - Before the impact of gains or losses related to hedge ineffectiveness and charges related to interest payments and amortization of debt discounts related to the 2025 Notes
Conference Call Details
A conference call to discuss the second quarter 2020 financial results is scheduled for today, August 6, 2020, at 10:00 a.m. Eastern Time. The U.S. toll free dial-in for the conference call is 866-754-6931 and the international dial-in is 636-812-6625. The conference passcode is 8585726. A live audio webcast of the conference call will be available on the “Investors” section of the Company’s website www.nationalvision.com/investors, where presentation materials will be posted prior to the conference call.
A telephone replay will be available shortly after the broadcast through Thursday, August 13, 2020, by dialing 855-859-2056 from the U.S. or 404-537-3406 from international locations, and entering conference passcode 8585726. A replay of the audio webcast will also be archived on the “Investors” section of the Company’s website.
About National Vision Holdings, Inc.
National Vision Holdings, Inc. is one of the largest optical retail companies in the United States with over 1,100 retail stores in 44 states plus the District of Columbia and Puerto Rico. With a mission of helping people by making quality eyecare and eyewear more affordable and accessible, the Company operates five retail brands: America’s Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores, Vista Opticals inside select Fred Meyer stores and on select military bases, and several e-commerce websites, offering a variety of products and services for customers’ eyecare needs.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934. These statements include, but are not limited to, statements related to our current beliefs and expectations regarding the performance of our industry, the Company's strategic direction, market position, prospects and future results. You can identify these forward-looking statements by the use of words such as “outlook,” “guidance,” “believes,” “expects,” “potential,” “continues,” “may,” “will,” “should,” “could,” “seeks,” “projects,” “predicts,” “intends,” “plans,” “estimates,” “anticipates” or the negative version of these words or other comparable words. Caution should be taken not to place undue reliance on any forward-looking statement as such statements speak only as of the date when made. We undertake no obligation to publicly update or review any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law. Forward-looking statements are not guarantees and are subject to various risks and uncertainties, which may cause actual results to differ materially from those implied in the forward-looking statements. Such factors include, but are not limited to, the scale, scope and duration of the novel coronavirus, or COVID-19, pandemic and its resurgence, and the impact of evolving federal, state, and local governmental actions in response thereto; customer behavior in response to the continuing pandemic and its resurgence, and evolving federal, state, and local governmental actions, including the impact of such behavior on in-store traffic and sales; our ability to keep our reopened stores open in a safe and cost-effective manner, or at all, in light of the continuing COVID-19 pandemic and its resurgence, and to open and operate new stores, and to successfully enter new markets in a timely and cost-effective manner; operational disruptions if a significant percentage of our workforce is unable to work or we experience labor shortages, including because of illness or travel or government restrictions in connection with the pandemic; the impact on our business of civil unrest, implementation of curfews and protests in certain locations, and related store closures or damage; our ability to recruit and retain vision care professionals for our stores in general and in light of the pandemic; our ability to develop and maintain relationships with managed vision care companies, vision insurance providers and other third-party payors; our ability to maintain the performance of our host and legacy brands and our current operating relationships with our host and legacy partners; our ability to adhere to extensive state, local and federal vision care and healthcare laws and regulations; our compliance with managed vision care laws and regulations; our ability to maintain sufficient levels of cash flow from our operations to execute or sustain our growth strategy; the loss of, or disruption in the operations of, one or more of our distribution centers and/or optical laboratories, resulting in the inability to fulfill customer orders and deliver our products in a timely manner; risks associated with vendors from whom our products are sourced, including our dependence on a limited number of suppliers; our ability to successfully compete in the highly competitive optical retail industry; any failure, inadequacy, interruption, security failure or breach of our information technology systems; our growth strategy straining our existing resources and causing the performance of our existing stores to suffer; the impact of wage rate increases, inflation, cost increases and increases in raw material prices and energy prices; our ability to successfully implement our marketing, advertising and promotional efforts; risks associated with leasing substantial amounts of space, including future increases in occupancy costs; the impact of certain technological advances, and the greater availability of, or increased consumer preferences for, vision correction alternatives to prescription eyeglasses or contact lenses, and future drug development for the correction of vision-related problems; our ability to retain our existing senior management team and attract qualified new personnel; overall decline in the health of the economy and consumer spending affecting consumer purchases; our ability to manage our inventory balances and inventory shrinkage; seasonal fluctuations in our operating results and inventory levels; our reliance on third-party coverage and reimbursement, including government programs, for an increasing portion of our revenues; risks associated with our e-commerce business; product liability, product recall or personal injury issues; our failure to comply with, or changes in, laws, regulations, enforcement activities and other requirements; the impact of any adverse litigation judgments or settlements resulting from legal proceedings relating to our business operations; risks of losses arising from our investments in technological innovators in the optical retail industry; our ability to adequately protect our intellectual property; our significant amount of indebtedness and our ability to generate sufficient cash flow to satisfy our significant debt service obligations; an increase in interest rates as well as changes in benchmark rates and uncertainty related to the foregoing; restrictions in our credit agreement that limits our flexibility in operating our business; and risks related to owning our common stock, including our ability to comply with requirements to design and implement and maintain effective internal controls. Additional information about these and other factors that could cause National Vision’s results to differ materially from those described in the forward-looking statements can be found in filings by National Vision with the Securities and Exchange Commission (“SEC”), including our Annual Report on Form 10-K, our Form 8-K filed on March 19, 2020, our Quarterly Reports on Form 10-Q filed on May 7, 2020 and August 6, 2020, and subsequent filings with the SEC, which are accessible on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in this release and in our filings with the SEC.
Non-GAAP Financial Measures
To supplement the Company’s financial information presented in accordance with GAAP and aid understanding of the Company’s business performance, the Company uses certain non-GAAP financial measures, namely “EBITDA,” “Adjusted EBITDA,” “Adjusted EBITDA Margin,” “Adjusted Operating Income,” “Adjusted Operating Margin,”, “Adjusted Diluted EPS,” “Adjusted SG&A” and “Adjusted SG&A Percent of Net Revenue.” We believe EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, Adjusted SG&A and Adjusted SG&A Percent of Net Revenue assist investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Management believes these non-GAAP financial measures are useful to investors in highlighting trends in our operating performance, while other measures can differ significantly depending on long-term strategic decisions regarding capital structure, the tax jurisdictions in which we operate and capital investments. Management uses these non-GAAP financial measures to supplement GAAP measures of performance in the evaluation of the effectiveness of our business strategies, to make budgeting decisions, to establish discretionary annual incentive compensation and to compare our performance against that of other peer companies using similar measures. Management supplements GAAP results with non-GAAP financial measures to provide a more complete understanding of the factors and trends affecting the business than GAAP results alone.
To supplement the Company’s comparable store sales growth presented in accordance with GAAP, the Company provides “Adjusted Comparable Store Sales Growth,” which is a non-GAAP financial measure we believe is useful because it provides timely and accurate information relating to the two core metrics of retail sales: number of transactions and value of transactions. Management uses Adjusted Comparable Store Sales Growth as the basis for key operating decisions, such as allocation of advertising to particular markets and implementation of special marketing programs. Accordingly, we believe that Adjusted Comparable Store Sales Growth provides timely and accurate information relating to the operational health and overall performance of each brand. We also believe that, for the same reasons, investors find our calculation of Adjusted Comparable Store Sales Growth to be meaningful.
In the first quarter of 2020, we introduced Adjusted Operating Income and Adjusted Operating Margin as measures of performance we will use in connection with Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Diluted EPS. Further, consistent with our presentation of Adjusted Operating Income, we no longer exclude new store pre-opening expenses and non-cash rent from our presentation of Adjusted EBITDA and Adjusted Diluted EPS. See our Form 8-K filed with the SEC on February 26, 2020 for more information.
Beginning with the first quarter of fiscal 2020, the Company updated its definitions of Adjusted EBITDA, Adjusted SG&A, and Adjusted Diluted EPS discussed below, so that they no longer exclude new store pre-opening expenses and non-cash rent.
EBITDA: We define EBITDA as net income (loss), plus interest expense, income tax provision (benefit) and depreciation and amortization.
Adjusted EBITDA: We define Adjusted EBITDA as net income (loss), plus interest expense, income tax provision (benefit) and depreciation and amortization, further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expenses, and other expenses.
Adjusted EBITDA Margin: We define Adjusted EBITDA Margin as Adjusted EBITDA as a percentage of net revenue.
Adjusted Operating Income: We define Adjusted Operating Income as net income (loss), plus interest expense and income tax provision (benefit), further adjusted to exclude stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, and other expenses.
Adjusted Operating Margin: We define Adjusted Operating Margin as Adjusted Operating Income as a percentage of net revenue.
Adjusted Diluted EPS: We define Adjusted Diluted EPS as diluted earnings (loss) per share, adjusted for the per share impact of stock compensation expense, asset impairment, litigation settlement, management realignment expenses, long-term incentive plan expenses, amortization of acquisition intangibles, amortization of debt discount and deferred financing costs, losses (gains) on change in fair value of derivatives, other expenses, and tax benefit of stock option exercises, less the tax effect of these adjustments.
Adjusted SG&A: We define Adjusted SG&A as SG&A, adjusted to exclude stock compensation expense, management realignment expenses, long-term incentive plan expenses, and other expenses except for the share of losses on equity method investments.
Adjusted SG&A Percent of Net Revenue: We define Adjusted SG&A Percent of Net Revenue as Adjusted SG&A divided by net revenue.
Adjusted Comparable Store Sales Growth: We measure Adjusted Comparable Store Sales Growth as the increase or decrease in sales recorded by the comparable store base in any reporting period, compared to sales recorded by the comparable store base in the prior reporting period, which we calculate as follows: (i) sales are recorded on a cash basis (i.e., when the order is placed and paid for or submitted to a managed care payor, compared to when the order is delivered), utilizing cash basis point of sale information from stores; (ii) stores are added to the calculation during the 13th full fiscal month following the store’s opening; (iii) closed stores are removed from the calculation for time periods that are not comparable; (iv) sales from partial months of operation are excluded when stores do not open or close on the first day of the month; and (v) when applicable, we adjust for the effect of the 53rd week. Quarterly, year-to-date and annual adjusted comparable store sales are aggregated using only sales from all whole months of operation included in both the current reporting period and the prior reporting period. When a partial month is excluded from the calculation, the corresponding month in the subsequent period is also excluded from the calculation. There may be variations in the way in which some of our competitors and other retailers calculate comparable store sales. As a result, our adjusted comparable store sales may not be comparable to similar data made available by other retailers. We did not adjust our calculation of Adjusted Comparable Store Sales Growth for the temporary closure of our stores to the public as a result of the COVID-19 pandemic.
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin, Adjusted Operating Income, Adjusted Operating Margin, Adjusted Diluted EPS, Adjusted SG&A, Adjusted SG&A Percent of Net Revenue, and Adjusted Comparable Store Sales Growth are not recognized terms under GAAP and should not be considered as an alternative to net income, the ratio of net income to net revenue as a measure of financial performance, SG&A, the ratio of SG&A to net revenue as a measure of financial performance, cash flows provided by operating activities as a measure of liquidity, comparable store sales growth as a measure of operating performance, or any other performance measure derived in accordance with GAAP. Additionally, these measures are not intended to be a measure of free cash flow available for management’s discretionary use as they do not consider certain cash requirements such as interest payments, tax payments and debt service requirements. The presentations of these measures have limitations as analytical tools and should not be considered in isolation, or as a substitute for analysis of our results as reported under GAAP. Because not all companies use identical calculations, the presentations of these measures may not be comparable to other similarly titled measures of other companies and can differ significantly from company to company.
Please see “Reconciliation of Non-GAAP to GAAP Financial Measures” below for reconciliations of non-GAAP financial measures used in this release to their most directly comparable GAAP financial measures.
National Vision Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
As of June 27, 2020 and December 28, 2019
In Thousands, Except Par Value Information
(Unaudited)
ASSETS
As of June 27, 2020
As of December 28, 2019
Current assets:
Cash and cash equivalents
$
256,292
39,342
Accounts receivable, net
58,451
44,475
Inventories
117,859
127,556
Prepaid expenses and other current assets
20,520
23,266
Total current assets
453,122
234,639
Property and equipment, net
339,905
366,767
Other assets:
Goodwill
777,613
Trademarks and trade names
240,547
Other intangible assets, net
53,236
56,940
Right of use assets
341,743
348,090
Other assets
12,871
8,129
Total non-current assets
1,765,915
1,798,086
Total assets
2,219,037
2,032,725
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
52,432
40,782
Other payables and accrued expenses
106,865
82,829
Unearned revenue
42,365
28,002
Deferred revenue
51,624
55,870
Current maturities of long-term debt and finance lease obligations
3,293
13,759
Current operating lease obligations
55,363
51,937
Total current liabilities
311,942
273,179
Long-term debt and finance lease obligations, less current portion and debt discount
644,941
555,933
Non-current operating lease obligations
328,453
331,769
Other non-current liabilities:
19,438
21,530
Other liabilities
25,928
13,731
Deferred income taxes, net
67,396
60,146
Total other non-current liabilities
112,762
95,407
Commitments and contingencies (See Note 9)
Stockholders’ equity:
Common stock, $0.01 par value; 200,000 shares authorized; 81,342 and 80,603 shares issued as of June 27, 2020 and December 28, 2019, respectively; 80,415 and 79,678 shares outstanding as of June 27, 2020 and December 28, 2019, respectively
812
805
Additional paid-in capital
782,851
700,121
Accumulated other comprehensive loss
(7,355)
(3,814)
Retained earnings
72,512
107,132
Treasury stock, at cost; 927 and 925 shares as of June 27, 2020 and December 28, 2019, respectively
(27,881)
(27,807)
Total stockholders’ equity
820,939
776,437
Total liabilities and stockholders’ equity
Condensed Consolidated Statements of Operations and Comprehensive Income
For the Three and Six Months Ended June 27, 2020 and June 29, 2019
In Thousands, Except Earnings Per Share
Three Months Ended
Six Months Ended
June 27, 2020
June 29, 2019
Revenue:
Net product sales
209,707
357,533
602,548
740,693
Net sales of services and plans
50,300
71,918
127,163
149,973
Total net revenue
260,007
429,451
729,711
890,666
Costs applicable to revenue (exclusive of depreciation and amortization):
Products
97,635
145,654
254,005
299,658
Services and plans
43,145
56,852
105,329
114,817
Total costs applicable to revenue
140,780
202,506
359,334
414,475
Operating expenses:
Selling, general and administrative expenses
136,582
182,278
330,323
376,154
Depreciation and amortization
21,924
20,819
46,734
41,234
Asset impairment
2,411
1,790
13,766
3,872
Litigation settlement
—
4,395
Other expense (income), net
(92)
356
(158)
829
Total operating expenses
160,825
205,243
395,060
422,089
Income (loss) from operations
(41,598)
21,702
(24,683)
54,102
Interest expense, net
15,502
8,968
22,957
18,029
Debt issuance costs
136
Earnings (loss) before income taxes
(57,236)
12,734
(47,776)
36,073
Income tax provision (benefit)
(13,403)
2,477
(13,685)
8,387
Net income (loss)
(43,833)
10,257
(34,091)
27,686
Earnings (loss) per share:
Basic
(0.55)
0.13
(0.42)
0.35
Diluted
0.34
Weighted average shares outstanding:
80,325
78,318
80,226
78,262
81,424
81,437
Comprehensive income (loss):
Unrealized gain (loss) on hedge instruments
4,111
(2,246)
(4,747)
(3,519)
Tax provision (benefit) of unrealized gain (loss) on hedge instruments
1,050
(576)
(1,206)
(902)
Comprehensive income (loss)
(40,772)
8,587
(37,632)
25,069
Condensed Consolidated Statements of Cash Flows
For the Six Months Ended June 27, 2020 and June 29, 2019
In Thousands
Cash flows from operating activities:
Adjustments to reconcile net income to net cash provided by operating activities:
Amortization of debt discount and deferred financing costs
2,717
892
Deferred income tax expense (benefit)
(13,686)
8,239
Stock based compensation expense
5,445
4,717
Losses (gains) on change in fair value of derivatives
4,871
Inventory adjustments
2,883
2,043
Credit loss expense
432
3,865
Other
1,373
1,592
Changes in operating assets and liabilities:
Accounts receivable
(14,408)
(10,567)
6,814
8,319
3,444
11,391
11,630
3,458
(6,338)
5,804
39,834
6,734
Net cash provided by operating activities
71,420
119,279
Cash flows from investing activities:
Purchase of property and equipment
(25,796)
(52,103)
265
315
Net cash used for investing activities
(25,531)
(51,788)
Cash flows from financing activities:
Borrowings on long-term debt, net of discounts
548,769
Repayments on long-term debt
(369,269)
(2,500)
Proceeds from exercise of stock options
5,998
2,066
Purchase of treasury stock
(74)
Payments of debt issuance costs
(12,400)
Payments on finance lease obligations
(1,587)
(1,190)
Net cash provided by (used for) financing activities
171,437
(1,624)
Net change in cash, cash equivalents and restricted cash
217,326
65,867
Cash, cash equivalents and restricted cash, beginning of year
40,307
17,998
Cash, cash equivalents and restricted cash, end of period
257,633
83,865
Supplemental cash flow disclosure information:
Cash paid for interest
13,810
17,438
Capital expenditures accrued at the end of the period
11,265
22,033
Right of use assets acquired under finance leases
1,257
9,763
Right of use assets acquired under operating leases
35,870
58,528
Reconciliation of Non-GAAP to GAAP Financial Measures
In Thousands, Except Per Share Information
Reconciliation of Adjusted Operating Income to Net Income
In thousands
(16.9)%
2.4%
(4.7)%
3.1%
Interest expense
6.0%
2.1%
2.0%
(5.2)%
0.6%
(1.9)%
0.9%
Stock compensation expense (a)
3,352
1.3%
1,741
0.4%
0.7%
0.5%
Asset impairment (b)
1.9%
Litigation settlement (c)
—%
Management realignment expenses (d)
2,155
0.2%
Long-term incentive plan (e)
781
722
0.1%
Amortization of acquisition intangibles (f)
1,851
3,702
Other (i)
(307)
(0.1)%
1,223
0.3%
1,149
2,467
Adjusted Operating Income / Adjusted Operating Margin
(34,427)
(13.2)%
29,088
6.8%
3,638
71,737
8.1%
Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding.
Some of the percentage totals in the table above do not foot due to rounding differences.
Reconciliation of EBITDA and Adjusted EBITDA to Net Income
8.4%
4.8%
6.4%
4.6%
EBITDA
(19,810)
(7.6)%
42,521
9.9%
21,915
3.0%
95,336
10.7%
Adjusted EBITDA / Adjusted EBITDA Margin
(14,354)
(5.5)%
48,056
11.2%
46,670
109,269
12.3%
Note: Percentages reflect line item as a percentage of net revenue, adjusted for rounding. Some of the percentage totals in the table above do not foot due to rounding differences
Reconciliation of Adjusted Diluted EPS to Diluted EPS
In thousands, except per share amounts
Diluted EPS
0.04
0.02
0.07
0.06
0.03
0.17
0.05
0.01
Amortization of debt discount and deferred financing costs (g)
Losses (gains) on change in fair value of derivatives (h)
Tax benefit of stock option exercises (j)
(0.01)
(0.04)
(0.02)
Tax effect of total adjustments (k)
(0.05)
(0.12)
(0.06)
Adjusted Diluted EPS
(0.41)
0.18
(0.13)
0.49
Weighted average diluted shares outstanding
Note: Some of the totals in the table above do not foot due to rounding differences
Reconciliation of Adjusted SG&A and Adjusted SG&A Percent of Net Revenue to SG&A
SG&A
52.5%
42.4%
45.3%
42.2%
Other (l)
776
1,460
Adjusted SG&A/ Adjusted SG&A Percent of Net Revenue
133,537
51.4%
178,980
41.7%
323,729
44.4%
367,100
41.2%
Note: Percentages reflect line item as a percentage of net revenue.
Reconciliation of Adjusted Comparable Store Sales Growth to Total Comparable Store Sales Growth
Comparable store sales growth(a)
Owned & Host segment
America’s Best
(37.1)
%
4.5
(22.2)
6.4
Eyeglass World
(31.6)
5.2
(21.2)
5.9
Military
(44.6)
0.3
(27.8)
(2.2)
Fred Meyer
(48.6)
(5.3)
(32.5)
(7.5)
Legacy segment
(35.8)
0.4
(24.4)
1.1
Total comparable store sales growth
(44.7)
4.4
(23.0)
5.4
Adjusted Comparable Store Sales Growth(b)
(36.5)
3.8
(22.6)
5.3
Additional Comparable Store Sales Growth information for Q2 2020
One Month Ended April 25, 2020
One Month Ended May 30, 2020
One Month Ended June 27, 2020
(83.9)
(56.6)
14.3
(86.6)
(38.5)
19.3
Investors:
National Vision Holdings, Inc.
David Mann, CFA, Vice President of Investor Relations
(470) 448-2448
[email protected]
Media:
Kristina Gross, Vice President of Communications
(470) 448-2355
me[email protected]
Twitter
Facebook
LinkedIn
YouTube
Blog
